We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTP
10151
DELISTED
Nam Tai Property Inc.
NTP
$90K ﹤0.01%
+15,349
New +$82K
AQMS icon
10152
PUT
Aqua Metals
AQMS
$8.89M
$89K ﹤0.01%
+149
New +$36.9K
KUST
10153
CALL
Kustom Entertainment Inc
KUST
$1M
0
IGC icon
10154
CALL
IGC Pharma
IGC
$25.9M
$89K ﹤0.01%
57,000
-33,000
-37% -$48.8K
GRCE
10155
Grace Therapeutics
GRCE
$35.5M
$89K ﹤0.01%
+5,699
New +$65.8K
ELYS
10156
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
$89K ﹤0.01%
+15,014
New +$39.2K
CSLT
10157
CALL
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$89K ﹤0.01%
68,500
-110,200
-62% -$124K
ATAXZ
10158
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
$89K ﹤0.01%
+20,844
New +$89K
CLSD
10159
CALL
DELISTED
Clearside Biomedical
CLSD
$88K ﹤0.01%
2,140
+1,447
+209% +$37.5K
SOGP
10160
Sound Group
SOGP
$53.8M
$88K ﹤0.01%
+2,256
New +$62K
TGB
10161
PUT
Trekor Metals
TGB
$2.86B
$88K ﹤0.01%
66,600
+30,600
+85% +$32.4K
WMC
10162
PUT
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$88K ﹤0.01%
2,690
-1,200
-31% -$32.5K
GSS
10163
PUT
DELISTED
Golden Star Resources Ltd.
GSS
$88K ﹤0.01%
23,600
+3,800
+19% +$15.4K
NMCI
10164
DELISTED
Navios Maritime Containers L.P. Common Units
NMCI
$88K ﹤0.01%
+21,561
New +$49.9K
DARE icon
10165
Dare Bioscience
DARE
$20.1M
$87K ﹤0.01%
+5,381
New +$75.4K
KYN icon
10166
CALL
Kayne Anderson Energy Infrastructure Fund
KYN
$2.42B
$87K ﹤0.01%
+15,200
New +$81.5K
PLX icon
10167
CALL
Protalix BioTherapeutics
PLX
$191M
$87K ﹤0.01%
24,100
+2,600
+12% +$9.32K
GENE
10168
DELISTED
Genetic Technologies Ltd.
GENE
$87K ﹤0.01%
+4,815
New +$79.5K
AAIC
10169
DELISTED
Arlington Asset Investment Corp.
AAIC
$87K ﹤0.01%
+23,020
New +$72K
FABC
10170
Fabric.AI Inc
FABC
$19.4M
$86K ﹤0.01%
110
-382
-78% -$232K
CLS icon
10171
CALL
Celestica
CLS
$42.7B
$86K ﹤0.01%
+10,600
New +$77.6K
OGI
10172
CALL
Organigram Holdings
OGI
$140M
$86K ﹤0.01%
+16,225
New +$83.3K
VEON icon
10173
VEON
VEON
$3.76B
$86K ﹤0.01%
+2,275
New +$81K
DSKE
10174
CALL
DELISTED
Daseke, Inc. Common Stock
DSKE
$86K ﹤0.01%
14,800
-3,200
-18% -$20.4K
ORTX
10175
CALL
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$86K ﹤0.01%
+1,990
New +$89.1K

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.